Obesity and its association with other non-transmitted chronic diseases
DOI:
https://doi.org/10.19230/jonnpr.2520Keywords:
association, obesity, ECNT, diabetes, hypertension, cancerAbstract
The World Health Organization (WHO) reports that around 312 million people in the world suffer from obesity, which is defined as "an abnormal or excessive accumulation of fat that can be harmful to health".
Aim. Evidence association between obesity and Chronic Noncommunicable Diseases ECNT in adults.
Method. A systematic review was carried out based on information published in databases such as Medline, ScienceDirect, INEGI and OMS.
Results. The information detected in the network indicates that there is sufficient evidence of the association between obesity and chronic noncommunicable diseases, including diabetes mellitus, hypertension and cancer, and it was found that work between government and society is necessary. , that is, with co-responsibility.
Conclusions. There is sufficient evidence of association between obesity and NCD, sedentary lifestyle, the socioeconomic conditions in which the vast majority of the Mexican population lives, the level of schooling and measures to mitigate incomplete obesity, such as labeling of food products without standard to compare and make the decision to consume them or not, among others. Disjointed programs of social reality, designed in the desktop or inherited, do not provide positive results.
Downloads
References
Simón Barquera Cervera, Ismael Campos-Nonato, Rosalba Rojas y Juan Rivera. Obesidad en México: epidemiología y políticas de salud para su control y prevención. Gaceta Médica de México. 2010; 146:397-407B
Fusco JP, Barrio MC, Denegri LN. Asociación entre índice de masa corporal elevado y valores de tensión arterial altas en el Centro de Salud Nº VII del barrio “Laguna Brava”. Revista de Posgrado de la VIa Cátedra de Medicina. 2006; 156: 1-3.
Barrera, A. Rodriguez, A. Molina, M. Escenario actual de la obesidad en Mexico, Revista Médica del Instituto Mexicano de Seguro Social [Internet], 2013, Vol. 51(8), Pag 1.
World Health Organizations (Internet). Obesity, 2016; visited 10- Nov- 2016; available in: http://www.who.int/es/
Vida.J., Enfermedades crónicas, relación con la obesidad, 2016, Disponible en: http://doctorjuliovida.com/enfermedades-cronicas/
Moreno M. Definición y clasificación de la obesidad. Rev. Med. Clin. CONDES. 2012; 23 (2): 124-128.
OMS. Estadísticas sanitarias mundiales,Indicadores de salud-Salud mundial-Servicios de salud – estadísticas-Mortalidad-Morbilidad- Esperanza de vida-Demografía-Estadística, Organización Mundial de la Salud, (2010).
Salim Yusuf, FRCP, DPhil; Srinath Reddy, MD; Stephanie Ôunpuu, PhD; Sonia Anand, FRCP(C), MSc; Global Burden of Cardiovascular Diseases, part 1: : General Considerations, the Epidemiologic Transition, Risk Factors, and Impact of Urbanization; Clinical Cardiology: New Frontiers; 2001.
Villa R, Escobedo M, Mendez S; Estimación y proyección de la prevalencia de obesidad en México a través de la mortalidad por enfermedades asociadas; Gac Méd Méx Vol.140, Suplemento No. 2, 2004.
Marchionni M, Caporale J, Conconi A, Porto N. Enfermedades crónicas no transmisibles y sus factores de riesgo en Argentina: prevalencia y prevención. Banco Interamericano de Desarrollo, Universidad Nacional de La Plata (2011).
Claudia P. Sánchez-Castillo, Edgar Pichardo-Ontiveros, Patricia López- R; Epidemiologia De La Obesidad; Gac Méd Méx Vol.140, Suplemento No. 2, 2004.
Carvajal Jorge. Guía para el análisis crítico de publicaciones científicas. Rev Chil Obstet Ginecol, 2004; 69 (1): 67-72.
Beltrán Oscar. Revisiones sistemáticas de la literatura. Rev. Colombiana de Gastroenterología; 20 (1) 2005: 60-69.
OMS. Dieta, nutrición y prevención de enfermedades crónicas. OMS, Serie de Informes Técnicos 916, (2003). Consulta Mixta OMS/FAO de Expertos en Régimen Alimentario, Nutrición y Prevención de Enfermedades Crónicas.
GRACIA. M. La obesidad como problema social: la ideación sobre su carácter crónico, plurifactorial y epidémico. Universitat Rovira i Virgili. (2012).
Clavijo, Z. Aspects to relationship between obesity and hypertension; 2009; The International Journal of Medicine and Science in Physical Education and Sport. 5(1):49-58
Dávila-Torres J et al. Panorama de la obesidad en México; Rev Med Inst Mex Seguro Soc. 2015;53(2):240-
World Health Organizations (WHO); Facts on obesity, 2008; visited 10- Nov- 2016; available in: http://www.who.int/features/factfiles/obesity/facts/en/
Antonio Barrera, Arturo Rodríguez, Mario Molina, Escenario actual de la obesidad en México, Rev Med Inst Mex 2103, Disponible en: http://www.medigraphic.com/pdfs/imss/im-2013/im133k.pdf.
Dra. Chan Magaret. Obesidad y diabetes: el desastre del movimiento lento Discurso principal en la 47ª reunión de la Academia Nacional de Medicina. Organización MundiaL de la SaluD. 2016, Disponible en: http://www.who.int/dg/speeches/2016/obesity-diabetes-disaster/en/
Encuesta Nacional de Salud y Nutrición. Obesidad en adultos: los retos de la cuesta abajo. ENSANUT [Internet], 2012, pag. 2-3.
Prado, C., Carmenate, M. M., Martínez, A. J., Díaz, M. E. y Toledo E. M. Composición corporal e hipertensión arterial en ancianos de La Habana, Cuba. 2001. Antropo, 0, 11-22.
Velázquez M. O., Rosas P. M., Lara E. A., Pastelín H. G., Sánchez C. C., Attie F. et al. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: Resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch. Cardiol. Méx. 2003:73(1): 62-77.
Martins D, Tareen N, Pan D, Norris K. The relationship between body mass index and pulse pressure in older adults with isolated systolic hypertension. Am J Hypertens 2002; 15: 538-543.
Fhigashi Y, Sasaki S, Nakgawa K, Matsuura H, Chayama K, Oshima T. Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension. Am J Hypertens 2001; 14: 1038-1045.
Zhang R, Reisin E. Obesity-hypertension: the effects on cardiovascular and renal system. Am J Hypertens 2000; 13: 1308-1314.
Hall J, Brands M, Dixon W, Smith MJ. Obesity-induced hypertension: renal function and system hemodynamic. Hypertension 1993, 22: 292- 299.
Kannel WD, Anderson K, Wilson PWF. Secular blood pressure trends in normotensive persons: the Framingham study. Am Heart J 1993; 125: 1154-1158.
Esler M. The sympathetic system and hipertensión. Am J Hypertens 2000; 13: S99-105.
Fhigashi Y, Sasaki S, Nakgawa K, Matsuura H, Chayama K, Oshima T. Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension. Am J Hypertens 2001; 14: 1038-1045
Rees DD, Palmer RMJ, Moncda S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proct Natl Acad Sci USA 1989; 86: 3375-3378.
Calver A, Collier J, Green D, Vallance P. Effect of acute plasma volume expansion on peripheral arteriolar tone in healthy subjects. Clin Sci 192; 85: 541-547.
Rönnemaa M, Karonen S-L, Rissanen A, Koskenvuo M, Koivisto VA. Relation between plasma leptin levels and measures of body fat in identical twins discordant for obesity. Am Intern Med 1995; 126: 26-31.
Kazushi T, Ichiro N. Leptin and membrane fluidity of erythrocytes in essential hypertension: an electron paramagnetic resonance investigation. Am J Hypertens 2004; 17: 375-379.
Xuequin J, Noboru F, Jinzi S, Hiroto T, Yimu L, Katsuo K et al. Effects of leptin on endothelial function with Ob-Rb gene transfer in Zucker fatty. Atherosclerosis 2003; 169: 225-233.
Adamczac M, Wicet A, Funashsashi T, Chudek J, Kokot F, Matsuzawa Y. Decreased plasma adiponectin in patients with essential hypertension. Am J Hypertens 2003; 16:72-75.
Sowera JR. Obesity as a cardiovascular risk factor. Am J Med 2003; 115 (Suppl 8): 37S-41S.
Murakami H, Ura N, Furuhashi M, Higashiura K, Miura t, Shimamoto K. Role of adiponectin in insulin-resistant hypertension and artherosclerosis. Hypertens Res 2003, 26: 705-710.
World Health Organization. Prevention of diabetes mellitus. Report of a WHO Study Group. Rev. Geneva: World Health Organization. (1994). v. 903. n. 844. Ago-Sept.
Le Roux. J. et al. Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study. Edit. Cardiovasc Diabetol. 3ra edición. Estados Unidos. (2011). pp.10- 39. 19.
Alexandra E. B., Janson J., Bonner-W.S., Ritzel R., Rizza A. R., and Butler C.P. β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes. Diabetes 2003 Jan; 52(1): 102-110.
Eringa, EC, Serne, EH, Meijer, RI y col. Endothelial dysfunction in (pre)diabetes: Characteristics, causative mechanisms and pathogenic role in type 2 diabetes. Rev Endocr Metab Disord (2013) 14: 39.
Ronald C. & et.al. Joslin’s Diabetes Mellitus. (2005). Edition 14th. Edit., Lippincott Williams Wilkins.
Vera O, Velasco M, Carballo J, Flores E, Espinoza M, De la Parte M et al. Insulinemia: relationship with obesity and high blood pressure. Am J Hypertens 2002; 15: A187.
Schmidt MI, Watson RL, Duncan BB, Metclaf P, Brancati FL, Sharrett AR et al. Clustering of dyslipemia, hyperuricemia, diabetes, and hyertension and its association with fasting insulin and central overall obesity in a general population. Metabolism 1996: 45: 699-706.
Hu RM, Levin ER, Pedram A, Frank HJL. Insulin stimulates production and secretion of endothelium from bovine endothelial cells. Diabetes 1993; 42: 351-358.
Esler M. Sympatheic nervus system and insulin resistance: from obesity to diabetes. Am J hypertens 2001; 14: A264.
Remesar X, Rafecas I, Alemany M, Fernández López JÁ. La obesidad ¿factor de riesgo para el cáncer? Nutrición y Obesidad 2000; 3: 194-01.
Rojas Martínez, María Rosalba, et al, “Epidemiología de la diabetes mellitus en México”, en Aguilar Salinas, Carlos A. et al, (eds), Acciones para enfrentar a la diabetes. Documento de postura. Academia Nacional de Medicina de México, México, 2015.
Diabetes, causa principal de muerte en México. Instituto Nacional De Salud Pública, México. Nov 2017. Disponible en: https://www.insp.mx/presencia-insp/3877-presenciainsp.html
Arredondo A. Costs, quality of care and financial consequences from diabetes in México: Implications to the Health System and to Patients. Health Care Collection, Nova Sci Publishers 2012.
Organización Panamericana de la Salud. Situación de la Salud de las Américas, Indicadores Básicos 2011. OMS 2011. [Consultado 2012 diciembre]. Disponible en: http://ais.paho.org/chi/brochures/2011/BI_2011_ESP.pdf.
Evans CA, Fielding JE, Brownson RC, Task_Force_on_Community_Preventive_Services. Strategies for reducing morbidity and mortality from diabetes through health- care system interventions and diabetes selfmanagement education in community settings. MMWR Recomm Rep 2001;50(RR16):1-15.
Rodríguez-Bolaños RA, Reynales-Shigematsu LM, Jiménez-Ruíz JA, Juárez-Márquez SA, Hernández-Ávila M. Costos directos de atención médica en pacientes con diabetes mellitus tipo 2 en México: análisis de microcosteo. Rev Panam de Salud Pública 2010;28:412-420.
Arredondo A. Requerimientos financieros para la demanda de servicios de salud por diabetes e hipertensión en México: 2001-2003. Rev Invest Clin 2001;35(5):422-429.
Arredondo A, Zúñiga A. Economic consequences of epidemiological changes in diabetes in middle-Income countries: the Mexican case. Diabetes Care 2004;27(1):104-109.
International Diabetes Federation. Atlas de Diabetes. Update 2012. 5th edición. Disponible en: http://www.idf.org/diabetesatlas/5e/Update2012.
World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC: AICR, 2007
Sánchez R César, Ibáñez Carolina, Klaassen Julieta. Obesidad y cáncer: la tormenta perfecta. Rev. méd. Chile [Internet]. 2014 Feb; 142 (2): 211-221. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000200010&lng=es.
Eheman C, Henley SJ, Ballard-Barbash R, Jacobs EJ, Schymura MJ, Noone AM, et al. Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 2012; 118:2338-66.
Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 2010; 61: 301- 16.
Karastergiou K, Mohamed-Ali V. The autocrine and paracrine roles of adipokines. Mol Cell Endocrinol 2010; 318: 69-78.
Cortés Ascencio, SY. Y Ruvalcaba Ledezma, JC. La corresponsabilidad en salud pública Viva Salud, INSP. Instituto Nacional de Salud Pública. (2011). pp. 40-43
Cortés Ascencio Sandra Yazmín, Jesús Carlos Ruvalcaba Ledezma, Avila Domínguez Rosangela, Torres Guevara Rosa Silvana, Calderón Rodríguez Nelly Patricia, Pérez Torres Lucia Vanessa, Barragán López Norma, Cobián Díaz Mariela Lizbeth, and Reynoso Vázquez Josefina, “Co- responsibility and Intercultural in Public Health.” American Journal of Public Health Research, 2017. vol. 5, (6): 174-180. DOI: 10.12691/ajphr- 5-6-2
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
